Tag: Crohn’s treatment side effects
New Hope for Kids with UC: Pfizer’s Oral Therapy Study Results
Pfizer’s new pediatric study of tofacitinib shows promising results for children with ulcerative colitis, offering hope for an oral treatment specifically tested in young patients. This could mean fewer hospital visits, better side effect profiles, and more treatment options designed specifically for our youngest IBD warriors.
Beyond Hope: 90+ New Crohn’s Therapies Could Change Everything
Over 90 new Crohn’s therapies are in development, with some showing remission rates three times higher than current treatments. This unprecedented surge in research could fundamentally change what it means to live with IBD.
AZD7798 for Crohn’s Disease: What AstraZeneca’s CALLISTO Trial Is Testing
AstraZeneca’s experimental treatment AZD7798 takes a precision approach to Crohn’s disease, targeting specific immune cells that cause gut inflammation rather than suppressing the entire immune system. This targeted therapy could offer new hope for patients seeking effective treatment with fewer side effects.
Hope on the Horizon: New Crohn’s Trial May Change Everything for Kids
AbbVie announces a promising new clinical trial studying Upadacitinib for children and teens with moderate to severe Crohn’s disease. This research could expand treatment options for our youngest IBD warriors who have historically had fewer therapeutic choices than adults.
Risankizumab vs Ustekinumab for Crohn’s: Phase 3 Head-to-Head Results
New Phase 3 study results show risankizumab offering hope for Crohn’s patients who haven’t responded to anti-TNF therapies. The treatment’s convenient home delivery system is also improving patient confidence and quality of life.
New Crohn’s Treatment Shows Promise for True Healing
New clinical trial results show risankizumab achieving 52% remission rates and actual tissue healing in Crohn’s patients. This breakthrough suggests we may be moving beyond symptom management toward true intestinal repair.
New Hope: Revolutionary Crohn’s Therapy Enters Clinical Trials
Researchers at the Hudson Institute have developed a groundbreaking therapy for perianal Crohn’s disease using extracellular vesicles that could sidestep the cost and accessibility challenges of traditional stem cell treatments. This innovative approach has entered clinical trials, offering new hope for patients with one of IBD’s most challenging manifestations.
Sara Levitt Shows Crohn’s Won’t Stop Her Miss Universe Dream
Miss Universe Canada contestant Sara Levitt is showing the world that Crohn’s disease won’t stop her from achieving her dreams. Her openness about living with IBD is creating powerful representation for our community and changing perceptions about what’s possible with chronic illness.
